Excerpt:
The U.S. Food and Drug Administration on Saturday authorized use of the J&J vaccine. The drug company had made nearly four million doses for initial shipment. The administration said it expected about 20 million doses to be delivered by the end of March.
Distribution will be uneven early on as the company increases production, it said, meaning the bulk of the additional 16 million doses will arrive later in the month.
“We’re getting these doses out the door as soon as they’re available to ensure vaccines get into arms as quickly as possible,” a senior Biden administration official said Sunday.
Author(s): Peter Loftus and Ken Thomas
Publication Date: 1 March 2021
Publication Site: Wall Street Journal